Cargando…

Cisplatin and carboplatin pharmacokinetics in a pediatric patient with hepatoblastoma receiving peritoneal dialysis

PURPOSE: Cisplatin and carboplatin are frequently used drugs in the treatment of pediatric hepatoblastoma. Dosing guidelines for these drugs in children requiring peritoneal dialysis are lacking. Here, we describe the case of a 3-year-old boy with pre-existing end-stage renal disease on peritoneal d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nijstad, A. Laura, van Eijkelenburg, Natasha K. A., Kraal, Kathelijne C. J. M., Meijs, Marieke J. M., de Kanter, Clara T. M. M., Lilien, Marc R., Huitema, Alwin D. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479000/ https://www.ncbi.nlm.nih.gov/pubmed/32816154 http://dx.doi.org/10.1007/s00280-020-04130-z

Ejemplares similares

Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.
por: English, M. W., et al.
Publicado: (1996)

Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment
por: Heijns, Joan B., et al.
Publicado: (2008)

A phase I and pharmacokinetic study of indisulam in combination with carboplatin
por: Dittrich, C, et al.
Publicado: (2007)

Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin.
por: Los, G., et al.
Publicado: (1994)

Population pharmacokinetics of clofarabine for allogeneic hematopoietic cell transplantation in paediatric patients
por: Nijstad, A. Laura, et al.
Publicado: (2021)

Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy.
por: Peng, B., et al.
Publicado: (1997)

PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma
por: Marayati, Raoud, et al.
Publicado: (2021)

Pharmacokinetics of Apixaban Among Peritoneal Dialysis Patients
por: Fung, Winston Wing-Shing, et al.
Publicado: (2023)

Pharmacokinetics of Intraperitoneal Vancomycin and Amikacin in Automated Peritoneal Dialysis Patients With Peritonitis
por: Falbo dos Reis, Pâmela, et al.
Publicado: (2021)

A Population Pharmacokinetic Modelling Approach to Unravel the Complex Pharmacokinetics of Vincristine in Children
por: Nijstad, A. Laura, et al.
Publicado: (2022)

Treatment-Related Toxicities During Anti-GD2 Immunotherapy in High-Risk Neuroblastoma Patients
por: Blom, Thomas, et al.
Publicado: (2021)

Cisplatin/carboplatin cross-resistance in ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1989)

Intraperitoneal pharmacokinetics of vancomycin in patients on automated peritoneal dialysis
por: Lam, Edwin, et al.
Publicado: (2021)

Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats.
por: Ohno, S., et al.
Publicado: (1993)

Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics
por: Peyro-Saint-Paul, Laure, et al.
Publicado: (2023)

Peritoneal Dialysis
por: Pyper, R. A.
Publicado: (1948)

Overestimation of the effect of (fos)aprepitant on intravenous dexamethasone pharmacokinetics requires adaptation of the guidelines for children with chemotherapy-induced nausea and vomiting
por: Nijstad, A. Laura, et al.
Publicado: (2022)

Evaluation of pharmacokinetics and safety of cetuximab with cisplatin/carboplatin in patients with advanced solid tumor: Result from phase II studies
por: Perez, Raymond P., et al.
Publicado: (2019)

Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications
por: Hartinger, Jan Miroslav, et al.
Publicado: (2023)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology
por: Bruin, Maaike A. C., et al.
Publicado: (2022)

Psychiatrist and Peritoneal Dialysis
por: Klarić, D., et al.
Publicado: (2022)

Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Tamoxifen
por: de Vries Schultink, Aurelia H. M., et al.
Publicado: (2015)

Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing
por: Verheijen, Remy B., et al.
Publicado: (2017)

‘Teratoid’ Hepatoblastoma: An Intriguing Variant of Mixed Epithelial-Mesenchymal Hepatoblastoma
por: Sergi, Consolato M., et al.
Publicado: (2022)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Comparative gonadotoxicity of the chemotherapy drugs cisplatin and carboplatin on prepubertal mouse gonads
por: Allen, Caroline M, et al.
Publicado: (2020)

APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures
por: Morcrette, Guillaume, et al.
Publicado: (2019)

Intraperitoneal meropenem for peritoneal dialysis peritonitis with Serratia marcescens immediately on commencing dialysis
por: Bhave, P., et al.
Publicado: (2016)

Long-term platinum retention after treatment with cisplatin and oxaliplatin
por: Brouwers, Elke EM, et al.
Publicado: (2008)

Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines.
por: Rantanen, V., et al.
Publicado: (1994)

Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk Neuroblastoma Patients over 18 Months at Diagnosis
por: Tas, Michelle L., et al.
Publicado: (2021)

Peritoneal Dialysis
por: Taskapan, Hulya, et al.
Publicado: (2011)

Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer
por: Kim, Eric S., et al.
Publicado: (2017)

Influence of single and multiple doses of amifostine on the efficacy and the pharmacokinetics of carboplatin in mice.
por: Korst, A. E., et al.
Publicado: (1997)

A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide.
por: McClay, E. F., et al.
Publicado: (1993)

Retreatment with Cisplatin May Provide a Survival Advantage for Children with Relapsed/Refractory Hepatoblastoma: An Institutional Experience
por: Somers, Katherine M., et al.
Publicado: (2023)

Peritoneal Dialysis Complicated by Sclerosing Peritonitis
por: Jiang, Zhifeng, et al.
Publicado: (2022)

A missed opportunity – consequences of unknown levetiracepam pharmacokinetics in a peritoneal dialysis patient
por: Bahte, Svenja K, et al.
Publicado: (2014)

Chemical conversion of cisplatin and carboplatin with histidine in a model protein crystallized under sodium iodide conditions
por: Tanley, Simon W. M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_prlkcglfnhlp0td7nknbvsvout